Published in Br J Dermatol on May 01, 2007
RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol (2011) 3.43
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest (2012) 2.01
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer. Mar Drugs (2015) 0.82
Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing. Oncotarget (2016) 0.80
Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study. Indian J Dermatol (2013) 0.77
Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes. Exp Dermatol (2010) 0.77
Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses. BMC Infect Dis (2013) 0.77
Genetic alterations in seborrheic keratoses. Oncotarget (2017) 0.75
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol (1994) 2.88
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol (1998) 2.82
Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol (2007) 1.89
Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol (2000) 1.76
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol (1993) 1.73
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol (2001) 1.67
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
[Flavonoids of Artemisia campestris, ssp. glutinosa]. Planta Med (1982) 1.55
Antibodies to hepatitis C virus. Lancet (1989) 1.47
HIV-1 infection by artificial insemination. Lancet (1998) 1.44
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol (2007) 1.42
Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol (2015) 1.41
Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant (2008) 1.35
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol (2009) 1.28
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer (1998) 1.28
Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol (2007) 1.26
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol (1999) 1.26
The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proc Natl Acad Sci U S A (1992) 1.24
Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol (2007) 1.21
Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis (1998) 1.19
Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res (2000) 1.17
Fast light-regulated genes of Neurospora crassa. Nucleic Acids Res (1989) 1.16
The natural history of actinic keratosis: a systematic review. Br J Dermatol (2013) 1.14
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev (2001) 1.13
Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III. J Virol Methods (1987) 1.13
Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. Oncogene (2006) 1.12
Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol (2007) 1.11
Gastrointestinal chemosensation: chemosensory cells in the alimentary tract. Histochem Cell Biol (2012) 1.11
Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol (1990) 1.08
UV-induced squamous cell carcinoma--a role for antiapoptotic signalling pathways. Br J Dermatol (2009) 1.08
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett (2000) 1.08
The importance of individual nucleotides for the structure and function of rRNA molecules in E. coli. A mutagenesis study. FEBS Lett (1986) 1.06
Noninvasive diagnostic tools for nonmelanoma skin cancer. Br J Dermatol (2007) 1.05
Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis (1995) 1.04
Distribution of bacteria in the epidermal layers and hair follicles of the human skin. Skin Pharmacol Physiol (2011) 1.03
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol (2009) 1.01
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate (1993) 1.01
Androgen signal transduction and prostatic carcinoma. World J Urol (1994) 1.00
First case of HIV-1 subtype 0 infection in Germany. Infection (1996) 1.00
Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures. Br J Dermatol (2003) 0.99
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome. Leukemia (2011) 0.99
Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses. Dermatology (2009) 0.99
Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet (1992) 0.96
Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol (1998) 0.95
Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR. J Clin Microbiol (1997) 0.95
Evolution of funnel-revolver flowers and ornithophily in nasa (loasaceae). Plant Biol (Stuttg) (2006) 0.95
HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS (2000) 0.94
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol (2009) 0.94
Apoptosis pathways as promising targets for skin cancer therapy. Br J Dermatol (2007) 0.93
Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells. Cell Death Differ (2012) 0.93
ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis. Cell Death Dis (2013) 0.93
The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol (2007) 0.92
Sensitivity and specificity of eight commercial and one recombinant anti-HIV ELISA tests. Lancet (1987) 0.92
Polyphenon E: a new treatment for external anogenital warts. Br J Dermatol (2009) 0.92
Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening. Acta Obstet Gynecol Scand (2001) 0.91
Viral warts in organ transplant recipients: new aspects in therapy. Br J Dermatol (2003) 0.91
Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol (2009) 0.90
HIV-1 subtype O: epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV. Arch Virol Suppl (1996) 0.90
RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol (1998) 0.90
Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes. Int J Cancer (1999) 0.89
E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br J Dermatol (2006) 0.88
B lymphopoiesis is upregulated after orchiectomy and is correlated with estradiol but not testosterone serum levels in aged male rats. Horm Metab Res (2001) 0.88
Diagnosis of HIV-1 group O infection by polymerase chain reaction. Lancet (1995) 0.87
Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol (2012) 0.87
Assessing physicians' preferences on skin cancer treatment in Europe. Br J Dermatol (2012) 0.87
Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon. AIDS Res Hum Retroviruses (1999) 0.87
Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax. Cell Death Dis (2013) 0.86
Modulation of HIV-1 enhancer activity and virus production by cAMP. FEBS Lett (2001) 0.86
Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia. Int J Gynecol Cancer (2001) 0.86
Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol (2006) 0.85
High viral load of human wart-associated papillomaviruses (PV) but not beta-PV in cutaneous warts independent of immunosuppression. Br J Dermatol (2009) 0.85
Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay. AIDS Res Hum Retroviruses (1995) 0.85
Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj J (1996) 0.85
Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol (2012) 0.85
Actinic keratoses: non-invasive diagnosis for field cancerisation. Br J Dermatol (2007) 0.85
Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus. Pediatr Infect Dis J (1998) 0.84
L-ascorbic acid inhibits UVA-induced lipid peroxidation and secretion of IL-1alpha and IL-6 in cultured human keratinocytes in vitro. J Invest Dermatol (1997) 0.84
Certification of sun protection practices in a German child day-care centre improves children's sun protection--the 'SunPass' pilot study. Br J Dermatol (2009) 0.84
Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol (1998) 0.84
Immune response profiles in human skin. Br J Dermatol (2007) 0.84
HIV antigen screening in blood donors. Lancet (1987) 0.84
Evaluation of Bowen disease by in vivo reflectance confocal microscopy. Br J Dermatol (2011) 0.84
Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques (1995) 0.84
Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A. FEBS Lett (1989) 0.83
Frequency and spectrum of HPV types detected in cutaneous squamous-cell carcinomas depend on the HPV detection system: a comparison of four PCR assays. Dermatology (2000) 0.83
Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR. Int J Gynecol Pathol (1997) 0.83